Abstract: A semiconductor structure having a multiple-porous graphene layer includes a sapphire substrate, a single or multiple layer porous graphene film, and a gallium nitride layer. A fabrication method for forming the semiconductor structure having a single or multiple layer porous graphene film, includes: firstly, growing up the graphene on the copper foil; then, using the acetone and isopropyl alcohol to wash the sapphire substrate, and then using the nitrogen flow to dry up; transferring the graphene onto the semiconductor substrate, using the Poly(methyl methacrylate) to fix the single or multiple layer porous graphene film, and using the acetone to wash up; using the photolithography process to etch the whole surface of the multiple-porous graphene layer; and, using the metalorganic chemical vapor deposition to deposit gallium nitride on the single or multiple layer porous graphene film and the sapphire substrate.

Abstract: Described herein are compounds, pharmaceutical compositions and methods for inhibiting the expression of a vitamin D receptor target gene, inhibiting interactions between the vitamin D receptor and at least one vitamin D receptor coactivator, for treating cancer in a subject, and for inhibiting angiogenesis in a subject.

Abstract: Described herein are compounds, pharmaceutical compositions and methods for inhibiting the expression of a vitamin D receptor target gene, inhibiting interactions between the vitamin D receptor and at least one vitamin D receptor coactivator, for treating cancer in a subject, and for inhibiting angiogenesis in a subject.

Abstract: The present invention provides a semiconductor structure having a multiple-porous graphene layer, comprising a semiconductor substrate, a multiple-porous graphene layer, and a gallium nitride layer. And, the present invention provides that the fabrication method for forming the semiconductor structure having a multiple-porous graphene layer, comprises: firstly, growing up the graphene on the copper foil; then, using the acetone and isopropyl alcohol to wash the semiconductor substrate, and then using the nitrogen flow to dry up; transferring the graphene onto the semiconductor substrate, using the Poly(methyl methacrylate)to fix the multiple-porous graphene layer, and using the acetone to wash up; using the photolithography process to etch the whole surface of the multiple-porous graphene layer; and, using the metalorganic chemical vapor deposition to deposit gallium nitride on the multiple-porous graphene layer and the semiconductor substrate.

Abstract: Described herein are compounds, pharmaceutical compositions and methods for inhibiting the expression of a vitamin D receptor target gene, inhibiting interactions between the vitamin D receptor and at least one vitamin D receptor coactivator, for treating cancer in a subject, and for inhibiting angiogenesis in a subject.

Abstract: Described herein are compounds, pharmaceutical compositions and methods for inhibiting the expression of a vitamin D receptor target gene, inhibiting interactions between the vitamin D receptor and at least one vitamin D receptor coactivator, for treating cancer in a subject, and for inhibiting angiogenesis in a subject.

Abstract: Techniques for generating a software update include determining changes between a previous version of a software package and a new version of the software package. Whether each change can be implemented as automatic correction instructions that can be executed by a client computer system is determined. Automatic correction instructions are generated for changes that can be implemented as automatic correction instructions. Manual correction instructions are generated for changes that cannot be implemented as automatic correction instructions, including, for each of those changes, identifying a corresponding template for a text string for the change from a repository of templates and including the text string in the manual correction instruction.

Abstract: Techniques for generating a software update include determining changes between a previous version of a software package and a new version of the software package. Whether each change can be implemented as automatic correction instructions that can be executed by a client computer system is determined. Automatic correction instructions are generated for changes that can be implemented as automatic correction instructions. Manual correction instructions are generated for changes that cannot be implemented as automatic correction instructions, including, for each of those changes, identifying a corresponding template for a text string for the change from a repository of templates and including the text string in the manual correction instruction.

Abstract: Described herein are compounds, pharmaceutical compositions and methods for inhibiting the expression of a vitamin D receptor target gene, inhibiting interactions between the vitamin D receptor and at least one vitamin D receptor coactivator, for treating cancer in a subject, and for inhibiting angiogenesis in a subject.